Hanol Rosuvastatin Calcium Tablet 5 mg
Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
Hanol BioPharma Co., Ltd.
MFDS item code 201404420 · Approved 2014.09.26
This product's status changed to Expired on 2024.09.26. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improves dyslipidemia, inhibits the progression of atherosclerosis, and prevents cardiovascular disease
This medicine serves as an adjunct treatment for patients with hypercholesterolemia and hyperlipidemia who have difficulty controlling their condition with diet and exercise. It is particularly used in patients with primary hypercholesterolemia and familial hypercholesterolemia, as well as mixed dyslipidemia, and it lowers total cholesterol and LDL-cholesterol levels, slowing the progression of atherosclerosis. Additionally, it is used in pediatric patients with high cholesterol levels due to familial hypercholesterolemia. This drug is effective as an adjunct to dietary control in patients with dysbetalipoproteinemia. Furthermore, it helps in reducing the risk of stroke, myocardial infarction, and revascularization procedures in men over 50 and women over 60 who have elevated high-sensitivity C-reactive protein levels and risk factors for cardiovascular disease. This medicine is used for the reduction of hyperlipidemia and cardiovascular disease risk.
1. Primary hypercholesterolemia (including heterozygous familial hypercholesterolemia, type IIa), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, which controls the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or more according to LDL cholesterol levels, treatment goals, and patient response; it may be increased to a maximum of 20 milligrams per day. 3. Elderly patients: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
Aged 10 to 17 years: The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses greater than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. Adjust the dose at intervals of 4 weeks or more. Under 10 years of age: Safety and efficacy have not been established.
This drug should not be used in certain patients. For example, it should not be administered to those with allergies to its ingredients, severe liver dysfunction, muscle disorders, those taking specific medications concurrently, severely impaired kidney function, pregnant or breastfeeding women, and fertile women who are not using appropriate contraception. This medication carries a risk of muscle-related side effects, so if symptoms such as muscle pain or weakness occur, the patient should immediately inform their doctor and undergo examination. Particular caution is needed for those with impaired kidney function, hypothyroidism, a family history of, or a previous experience with muscle-toxic medications. Patients with liver dysfunction or those who consume excessive alcohol should have regular liver function tests before and during the use of this medication. Additionally, this drug may slightly increase blood sugar levels, so patients at risk for diabetes should be cautious with blood sugar management. If severe muscle pain, muscle weakness, fatigue, fever, or other symptoms appear while taking this drug, the patient should consult a healthcare professional immediately, as serious skin reactions or liver damage may occur; if symptoms like skin rash or jaundice appear, the medication should be stopped and the patient should go to a hospital. This drug may interact with other medications, so if the patient is currently taking any other medicines, they should inform their doctor or pharmacist, especially when taking specific antiviral agents, immunosuppressants, antibiotics, or fibrate medications. Pregnant women or those planning to become pregnant should not take this drug, and breastfeeding women should also avoid it. If pregnancy is confirmed while taking this medication, it should be immediately discontinued. In cases of overdose, there is no specific antidote, so treatment should be provided according to symptoms, with monitoring of liver function and muscle enzyme levels. Dizziness may occur while driving or operating machinery, so caution is advised. Finally, this drug may show higher blood concentrations in Asians, and dose adjustments may be necessary.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, asthenia, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, elevated transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, morbilliform drug rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorder, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, myalgia, increased CK, increased AST, joint pain, fatigue, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, abnormal liver function tests, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, acute renal failure, oliguria, increased serum creatinine
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly closed container. Additionally, it should be kept in a cool, dry place, ideally at room temperature between 1 and 30 degrees Celsius.
Yellow round film-coated tablets
28 tablets (14 tablets/PTPX2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
Hanol BioPharma Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.